Logistics, Process, Regulations
June 8, 2021
Via: Alliance for American ManufacturingThe White House on Tuesday unveiled a report with new initiatives to shore up supply chains for critical resources like semiconductors, batteries, rare earth minerals and pharmaceuticals. This all-of-government approach could bear positive economic implications, create new American jobs, and […]
October 16, 2020
Via: Industry TodayThe medical industry needs supplies devoid of harmful pathogens. Medical devices, such as retractors, urinary catheters, face masks for oxygen administration, and single-use anoscopes, should provide care without adding risks to patients and other users. Hence, it’s essential to have […]
Industry Focus Areas, Medical, Regulations
October 14, 2019
Via: Industry WeekJohnson & Johnson has taken some costly beatings in court this year. And it could get worse. Just last week, a jury ordered J&J to pay $8 billion for wrongfully pushing doctors to prescribe the anti-psychotic drug Risperdal. While the […]
Industry Focus Areas, Medical, Regulations
March 14, 2019
Via: Mass DeviceAerie Pharmaceuticals (NSDQ:AERI) said this week that the FDA approved the company’s once-daily eye drop Rocklatan for the treatment of elevated intraocular pressure in people with open-angle glaucoma or ocular hypertension. The Durham, N.C.-based company’s product is a fixed-dose combination […]
February 26, 2019
Via: Mass DeviceInsulet (NSDQ:PODD) posted its fourth-quarter and full-year financial results yesterday after the markets closed, beating estimates on Wall Street. The Acton, Mass.-based company posted profits of $9.9 million, or 17¢ per share, on sales of $164.9 million for the three […]
February 25, 2019
Via: Mass DeviceGlooko announced this month that it’s teaming up to connect Novo Nordisk‘s (NYSE:NVO) insulin pens with the company’s diasend diabetes management solution. Novo Nordisk plans to launch its connected insulin pens, the NovoPen 6 and NovoPen Echo Plus, in early […]
February 19, 2019
Via: Mass DeviceMedtronic (NYSE:MDT) said today that it won breakthrough status from the FDA for its investigational personalized closed-loop insulin pump system. The company touted its technology as enabling automated insulin delivery in a real-time, adaptable and personalized fashion. Medtronic’s November acquisition […]
Industry Focus Areas, Logistics, Medical, Process
January 15, 2019
Via: Mass DeviceWhat were the trends that drove the biopharma and drug delivery markets in 2018? Many of 2018’s key trends revolved around increasing regulatory requirements. However, as the market continues to move toward more personalized medicine, such as cell and gene […]
December 26, 2018
Via: Mass DeviceTeva (NYSE:TEVA) said this week that the FDA approved its ProAir Digihaler device – a digital inhaler that uses sensors to connect to a companion mobile app for people with asthma and chronic obstructive pulmonary disease. The company’s device features […]
December 6, 2018
Via: Mass DeviceImpel NeuroPharma said today that it raised $67.5 million in a Series D financing round, with investments from KKR, Norwest Venture Partners, Vivo Capital, 5Am Ventures and venBio Partners. The Seattle-based company plans to use the round’s proceeds to support […]
November 8, 2018
Via: Mass DeviceInsulet (NSDQ:PODD) said this week that it inked a deal with Samsung to develop an Omnipod insulin delivery system that would allow users to control their insulin pump therapy with a Galaxy smartphone. If approved, the system would be the […]
October 26, 2018
Via: Mass DeviceInovio Pharmaceuticals (NSDQ:INO) reported today that its synthetic HIV vaccine, Pennvax-GP, demonstrated durable antibody and T cell immune responses throughout a Phase I trial. The company found that Pennvax-GP plasmids delivered intradermally with Inovio’s Cellectra device triggered equivalent or superior […]
Industry Focus Areas, Medical, Regulations
October 24, 2018
Via: Mass DeviceXeris Pharmaceuticals (NSDQ:XERS) said today that the FDA accepted its new drug application for a ready-to-use liquid glucagon rescue pen device. The company’s product is designed to treat severe hypoglycemia in people with diabetes. The FDA is slated to make […]
September 25, 2018
Via: Mass DevicePrivately-held Dance Biopharm said yesterday that it raised $24.5 million in a private equity round to help fund the development of its inhaled insulin product. SternAegis Ventures was the exclusive placement agent for the offering. Molex Ventures, an electronics company […]
September 10, 2018
Via: Mass DeviceMedtronic (NYSE:MDT) said today that it’s launching a study in the U.S. and Japan to evaluate dual antiplatelet therapy in high bleeding risk patients implanted with the Resolute Onyx drug-eluting stent during percutaneous coronary intervention. The company’s Onyx One Clear […]
August 20, 2018
Via: Mass DeviceTandem Diabetes Care (NSDQ:TNDM) last week launched its t:slim X2 insulin pump with Basal-IQ technology in the U.S. The company’s latest pump includes a predictive low glucose suspend feature designed to reduce the frequency and duration of hypoglycemia. Using the […]
July 30, 2018
Via: Mass DeviceNanobiotix (PAR:NANO.PA) inked a non-dilutive financial deal with the European Investment Bank last week to support the development of its nanoparticle-based cancer therapies. The Paris, France-based company said it landed a five-year loan to borrow up to €40 million ($46.7 […]
May 9, 2018
Via: Mass DeviceAt least 400 people across the U.S. have had trouble getting their hands on an Epipen in recent weeks, according to a survey from the advocacy group Food Allergy Research & Education. Mylan (NSDQ:MYL), which makes the emergency allergy auto-injector, […]
Industry Focus Areas, Medical, Regulations
September 20, 2017
Via: Mass DeviceGlaxoSmithKline (NYSE:GSK) and Innoviva (NSDQ:INVA) notched a win this week after the FDA approved its once-daily, triple combination therapy for the treatment of chronic obstructive pulmonary disease. Last week, an EU agency recommended the inhaler’s approval. Now, the companies are […]
December 13, 2016
Via: Mass DevicePhillips-Medisize said today that it plans to open an 80,000 square foot drug delivery manufacturing facility at its Menomonie, Wisconsin campus. The facility, which is expected to open in 2017, will manufacture high volume, prefilled drug delivery systems. It will […]